Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 1, 2024Health Science ReportsOpen Access

Assessment of lytic therapy effect in patients with intermediate‐high risk pulmonary embolism for prevention of chronic thromboembolic pulmonary hypertension: A randomized, double‐blind trial

View Full Paper
Ask AI
Bookmark
Share

Authors

PMPejman MansouriARAmir RashidiMMMohammad Hadi Mansouri

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Mansouri et al. (2024) studied this question.

synapsesocial.com/papers/68e671c0b6db6435875fc033https://doi.org/10.1002/hsr2.2093
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Percutaneous Reperfusion Therapies vs. Anticoagulation in Patients With Acute Intermediate‐High‐Risk Pulmonary Embolism: The PRETHA Randomized Clinical Trial2026 · 1 citations
  2. 2A pilot randomised trial of catheter-directed thrombolysis or standard anticoagulation for patients with intermediate-high risk acute pulmonary embolism2022 · 51 citations
  3. 3Efficacy of transcatheter low-dose thrombolysis in patients with intermediate-high risk pulmonary embolism. Study rationale and design2025 · 1 citations
  4. 4The effects of thrombolytic therapy on prognostic clinical markers in patients with intermediate-high risk pulmonary embolism2020 · 1 citations
  5. 5Comparison of half-dose alteplase and LMWH in intermediate-high risk pulmonary embolism: a single-center observational study2025 · 1 citations